4//SEC Filing
LaFrence Andrew D.C. 4
Accession 0001493152-21-012504
CIK 0001349929other
Filed
May 20, 8:00 PM ET
Accepted
May 21, 4:05 PM ET
Size
5.4 KB
Accession
0001493152-21-012504
Insider Transaction Report
Form 4
Vyant Bio, Inc.VYNT
LaFrence Andrew D.C.
Chief Financial Officer
Transactions
- Purchase
Common Stock, $0.0001 par value
2021-05-20$3.28/sh+3,000$9,837→ 32,336 total
Holdings
- 26,866(indirect: By Trust)
Common Stock, $0.0001 par value
Documents
Issuer
Vyant Bio, Inc.
CIK 0001349929
Entity typeother
Related Parties
1- filerCIK 0001850633
Filing Metadata
- Form type
- 4
- Filed
- May 20, 8:00 PM ET
- Accepted
- May 21, 4:05 PM ET
- Size
- 5.4 KB